title: Stem cell transplantation.
abstract: Stem cell transplantation in pediatric patients with leukemia has been a matter of debate since the first successful transplantation in a child with aplastic anemia in Germany in 1975. Since then, there has been a long way to implement fully stem cell transplantation strategies into the treatment studies organized within BFM Groups for first line or second line treatment of acute and chronic leukemias and myelodysplastic syndrome. The role of different risk groups, different donors, stem cell sources and alternative approaches as haploidentical transplantation as well have been studied as the impact of chimerism and minimal residual disease. Finally, for all leukemias and myelodysplastic syndromes integrated treatment pathways have been developed, which integrate stem cell transplantation on an evidence base into the treatment of the patient.
authors.affiliation: Pediatric Hospital, University of Tübingen, Germany. Dietrich.niethammer@t-online.de
authors.forename: D
authors.initials: D
authors.lastname: Niethammer
authors.forename: P
authors.initials: P
authors.lastname: Bader
authors.forename: R
authors.initials: R
authors.lastname: Handgretinger
authors.forename: T
authors.initials: T
authors.lastname: Klingebiel
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002648:Child; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D019317:Evidence-Based Medicine; D005858:Germany; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D007938:Leukemia / Q000628:therapy*; D009190:Myelodysplastic Syndromes / Q000628:therapy